Tumor infiltrating lymphocytes (TIL) LN-145
2000025837
Phase 2 small_molecule completed
Quick answer
Tumor infiltrating lymphocytes (TIL) LN-145 for Metastatic Triple Negative Breast Cancer is a Phase 2 program (small_molecule) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IOVANCE BIOTHERAPEUTICS, INC.
- Indication
- Metastatic Triple Negative Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed